Jinming Yang
Last active: 3/14/2017

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma. Yang J, Kantrow S, Sai J, Hawkins OE, Boothby M, Ayers GD, Young ED, Demicco EG, Lazar AJ, Lev D, Richmond A (2012) Cancer Res 72(18): 4682-95
    › Primary publication · 22836752 (PubMed) · PMC3459578 (PubMed Central)
  2. NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway. Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A (2012) Oncogene 31(20): 2580-92
    › Primary publication · 21963849 (PubMed) · PMC3253179 (PubMed Central)
  3. Conditional ablation of Ikkb inhibits melanoma tumor development in mice. Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A (2010) J Clin Invest 120(7): 2563-74
    › Primary publication · 20530876 (PubMed) · PMC2898608 (PubMed Central)
  4. Monitoring NF-kappaB mediated chemokine transcription in tumorigenesis. Yang J, Richmond AJ (2009) Methods Enzymol : 347-55
    › Primary publication · 19446734 (PubMed) · PMC3140415 (PubMed Central)
  5. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R, Richmond A (2009) Mol Cancer Ther 8(3): 636-47
    › Primary publication · 19276165 (PubMed) · PMC3140401 (PubMed Central)
  6. The good and the bad of chemokines/chemokine receptors in melanoma. Richmond A, Yang J, Su Y (2009) Pigment Cell Melanoma Res 22(2): 175-86
    › Primary publication · 19222802 (PubMed) · PMC2848967 (PubMed Central)
  7. Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Yang J, Pan WH, Clawson GA, Richmond A (2007) Cancer Res 67(7): 3127-34
    › Primary publication · 17409419 (PubMed) · PMC2665271 (PubMed Central)
  8. Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Yang J, Su Y, Richmond A (2007) Free Radic Biol Med 42(9): 1369-80
    › Primary publication · 17395010 (PubMed) · PMC1905840 (PubMed Central)
  9. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Yang J, Amiri KI, Burke JR, Schmid JA, Richmond A (2006) Clin Cancer Res 12(3 Pt 1): 950-60
    › Primary publication · 16467110 (PubMed) · PMC2668250 (PubMed Central)
  10. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Yang J, Richmond A (2004) Mol Ther 9(6): 846-55
    › Primary publication · 15194051 (PubMed) · PMC2668261 (PubMed Central)
  11. How do chemokine/chemokine receptor activations affect tumorigenesis? Richmond A, Fan GH, Dhawan P, Yang J (2004) Novartis Found Symp : 74-89; discussion 89-91, 106-11, 266-9
    › Primary publication · 15027484 (PubMed)
  12. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Yang J, Luan J, Yu Y, Li C, DePinho RA, Chin L, Richmond A (2001) Cancer Res 61(22): 8150-7
    › Primary publication · 11719444 (PubMed)
  13. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. Yang J, Fan GH, Wadzinski BE, Sakurai H, Richmond A (2001) J Biol Chem 276(51): 47828-33
    › Primary publication · 11591705 (PubMed) · PMC2665282 (PubMed Central)
  14. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Yang J, Richmond A (2001) Cancer Res 61(12): 4901-9
    › Primary publication · 11406569 (PubMed)

Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    2220 Pierce Avenue
    432 Preston Research Building
    Nashville, TN 37232-6840
    United States
    ((615) 343 7780 (p)
    Email

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Amino Acid Motifs Aurora Kinase A Base Sequence beta Catenin Blotting, Western Capillaries Cell Survival Chemokine CXCL1 Chemokines Crosses, Genetic Cyclin-Dependent Kinase 4 Cyclin D2 Disease Models, Animal Enzyme Activation Flow Cytometry Gene Expression Regulation, Neoplastic Genes, myc Interleukin-1 Luciferases Mice Neoplasms NF-kappa B Promoter Regions, Genetic Protein-Serine-Threonine Kinases Protein Binding Pyridines RNA, Messenger RNA, Small Interfering Skin Neoplasms Up-Regulation